As capital positions itself for the anticipated debut of SpaceX, Rocket Lab shares have experienced a notable pullback alongside most public space companies. Over the past month, the company’s stock has declined by double digits as investors preserve liquidity for the florid valuations expected in the private market. Despite Rocket Lab’s leadership in small-satellite launches, market participants are adopting a conservative stance, choosing to redeploy funds only once SpaceX’s offering materializes and valuation clarity emerges.

Rocket Lab is set to report fourth-quarter results backed by a Space Systems segment that contributed roughly 70% of total revenue, underpinning strong gross margins. Analysts forecast that the reported top line should comfortably surpass consensus, given that Neutron-related production delays will not affect fourth-quarter deliveries of the expendable Electron vehicle. Management’s commentary will be crucial, as any dovish tone around full-year guidance could trigger a re-rating of the stock’s premium multiple.

A January incident involving a Stage 1 tank rupture during ground testing has heightened concerns over the timeline for Rocket Lab’s reusable Neutron rocket debut. While the company continues to target mid-year completion of assembly and hot-fire qualification, engineers now face a condensed schedule to meet previously disclosed operational milestones. Should Neutron slip beyond planned launch windows, consensus estimates for 2027 launch cadence and associated revenue streams could be revised lower, potentially compressing the multiple investors currently assign to the growth trajectory.